Ho Lee , Mingyu Kang , Sung Hoon Sim , Joon Hee Kang , Wonyoung Choi , Jung Won Chun , Woosol Hong , Chaeyoung Kim , Woojin Ham , Jeong Hwan Park , Eun-Byeol Koh , Yoon Jeon , Sang Myung Woo , Soo-Youl Kim
{"title":"敲除ACAA1通过激活自噬提高KPC小鼠的存活率","authors":"Ho Lee , Mingyu Kang , Sung Hoon Sim , Joon Hee Kang , Wonyoung Choi , Jung Won Chun , Woosol Hong , Chaeyoung Kim , Woojin Ham , Jeong Hwan Park , Eun-Byeol Koh , Yoon Jeon , Sang Myung Woo , Soo-Youl Kim","doi":"10.1016/j.molmet.2025.102237","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>We found that the levels of the peroxisomal fatty acid oxidation (FAO) marker in pancreatic ductal adenocarcinoma (PDAC) patients were higher than those in healthy individuals, based on tissue microarray analysis. This study investigates FAO in preclinical in vitro and in vivo models.</div></div><div><h3>Methods</h3><div>To examine the role of FAO in the peroxisome, we created acetyl-coenzyme A acyltransferase (ACAA1) knockout mice, crossed them with KPC mice, and monitored their survival rates. Additionally, we tested a mouse xenograft model with ACAA1 knockdown in human PDAC cells.</div></div><div><h3>Results</h3><div>In normal cells, <em>ACAA1</em> knockdown did not affect oxygen consumption. In contrast, in PDAC cells, <em>ACAA1</em> knockdown reduced the oxygen consumption rate by up to 60% and decreased ATP production by up to 70%. This suggests that peroxisomes in PDAC supply various acyl-carnitines for FAO in mitochondria. In PDAC cells, <em>ACAA1</em> knockdown lowered ATP levels, resulting in mTOR inactivation and autophagy induction. Additionally, <em>ACAA1</em> knockdown significantly increased LC3-II levels, leading to growth retardation in mouse xenograft models. <em>Acaa1a</em><sup><em>+/−</em></sup> mice showed a median survival increase of 3 weeks after crossing <em>Acaa1a</em><sup><em>+/−</em></sup> with KPC mice (<em>Kras</em><sup>G12D/+</sup>; <em>Trp53</em><sup>R172H/+;</sup> <em>Pdx1</em>-Cre, a genetically engineered mice model for PDAC).</div></div><div><h3>Conclusions</h3><div><em>ACAA1</em> knockdown inhibited tumor growth by triggering autophagy, which supported the survival of KPC mice. The most important benefit of targeting ACAA1 is that it blocks tumor growth specifically in cancer cells without harming normal cell energy metabolism.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"100 ","pages":"Article 102237"},"PeriodicalIF":6.6000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ACAA1 knockout increases the survival rate of KPC mice by activating autophagy\",\"authors\":\"Ho Lee , Mingyu Kang , Sung Hoon Sim , Joon Hee Kang , Wonyoung Choi , Jung Won Chun , Woosol Hong , Chaeyoung Kim , Woojin Ham , Jeong Hwan Park , Eun-Byeol Koh , Yoon Jeon , Sang Myung Woo , Soo-Youl Kim\",\"doi\":\"10.1016/j.molmet.2025.102237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>We found that the levels of the peroxisomal fatty acid oxidation (FAO) marker in pancreatic ductal adenocarcinoma (PDAC) patients were higher than those in healthy individuals, based on tissue microarray analysis. This study investigates FAO in preclinical in vitro and in vivo models.</div></div><div><h3>Methods</h3><div>To examine the role of FAO in the peroxisome, we created acetyl-coenzyme A acyltransferase (ACAA1) knockout mice, crossed them with KPC mice, and monitored their survival rates. Additionally, we tested a mouse xenograft model with ACAA1 knockdown in human PDAC cells.</div></div><div><h3>Results</h3><div>In normal cells, <em>ACAA1</em> knockdown did not affect oxygen consumption. In contrast, in PDAC cells, <em>ACAA1</em> knockdown reduced the oxygen consumption rate by up to 60% and decreased ATP production by up to 70%. This suggests that peroxisomes in PDAC supply various acyl-carnitines for FAO in mitochondria. In PDAC cells, <em>ACAA1</em> knockdown lowered ATP levels, resulting in mTOR inactivation and autophagy induction. Additionally, <em>ACAA1</em> knockdown significantly increased LC3-II levels, leading to growth retardation in mouse xenograft models. <em>Acaa1a</em><sup><em>+/−</em></sup> mice showed a median survival increase of 3 weeks after crossing <em>Acaa1a</em><sup><em>+/−</em></sup> with KPC mice (<em>Kras</em><sup>G12D/+</sup>; <em>Trp53</em><sup>R172H/+;</sup> <em>Pdx1</em>-Cre, a genetically engineered mice model for PDAC).</div></div><div><h3>Conclusions</h3><div><em>ACAA1</em> knockdown inhibited tumor growth by triggering autophagy, which supported the survival of KPC mice. The most important benefit of targeting ACAA1 is that it blocks tumor growth specifically in cancer cells without harming normal cell energy metabolism.</div></div>\",\"PeriodicalId\":18765,\"journal\":{\"name\":\"Molecular Metabolism\",\"volume\":\"100 \",\"pages\":\"Article 102237\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212877825001449\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Metabolism","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212877825001449","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
ACAA1 knockout increases the survival rate of KPC mice by activating autophagy
Objectives
We found that the levels of the peroxisomal fatty acid oxidation (FAO) marker in pancreatic ductal adenocarcinoma (PDAC) patients were higher than those in healthy individuals, based on tissue microarray analysis. This study investigates FAO in preclinical in vitro and in vivo models.
Methods
To examine the role of FAO in the peroxisome, we created acetyl-coenzyme A acyltransferase (ACAA1) knockout mice, crossed them with KPC mice, and monitored their survival rates. Additionally, we tested a mouse xenograft model with ACAA1 knockdown in human PDAC cells.
Results
In normal cells, ACAA1 knockdown did not affect oxygen consumption. In contrast, in PDAC cells, ACAA1 knockdown reduced the oxygen consumption rate by up to 60% and decreased ATP production by up to 70%. This suggests that peroxisomes in PDAC supply various acyl-carnitines for FAO in mitochondria. In PDAC cells, ACAA1 knockdown lowered ATP levels, resulting in mTOR inactivation and autophagy induction. Additionally, ACAA1 knockdown significantly increased LC3-II levels, leading to growth retardation in mouse xenograft models. Acaa1a+/− mice showed a median survival increase of 3 weeks after crossing Acaa1a+/− with KPC mice (KrasG12D/+; Trp53R172H/+;Pdx1-Cre, a genetically engineered mice model for PDAC).
Conclusions
ACAA1 knockdown inhibited tumor growth by triggering autophagy, which supported the survival of KPC mice. The most important benefit of targeting ACAA1 is that it blocks tumor growth specifically in cancer cells without harming normal cell energy metabolism.
期刊介绍:
Molecular Metabolism is a leading journal dedicated to sharing groundbreaking discoveries in the field of energy homeostasis and the underlying factors of metabolic disorders. These disorders include obesity, diabetes, cardiovascular disease, and cancer. Our journal focuses on publishing research driven by hypotheses and conducted to the highest standards, aiming to provide a mechanistic understanding of energy homeostasis-related behavior, physiology, and dysfunction.
We promote interdisciplinary science, covering a broad range of approaches from molecules to humans throughout the lifespan. Our goal is to contribute to transformative research in metabolism, which has the potential to revolutionize the field. By enabling progress in the prognosis, prevention, and ultimately the cure of metabolic disorders and their long-term complications, our journal seeks to better the future of health and well-being.